TORONTO, Sept. 26, 2022 /CNW/ – RIV Capital Inc. an acquisition and investment firm focused on building a leading multistate platform with the strongest portfolio of cannabis brands in key strategic markets across the United States, reminds shareholders that the deadline for voting FOR the Company’s board of director’s nominees is 10:00 a.m. (EDT) on September 27, 2022.
“We believe that our Board nominees will execute on RIV Capital’s strategic vision to become a leader in the industry and capitalize on the lucrative growth of the market in the years ahead,” said Mark Sims, Director, President and CEO, RIV Capital. “Under its guidance and stewardship, we believe that the Company will continue to create long-term shareholder value. Without a doubt, the future is bright for RIV Capital.”
The upcoming Annual General Meeting will be held on Thursday, September 29, 2022 at 10:00 a.m. (EDT). RIV Capital urges shareholders to visit rivcapital.com/future for more information about our Board nominees and to vote before the deadline of 10:00 a.m. (EDT) on September 27, 2022.
About RIV Capital
RIV Capital is a cannabis packaged goods company, with a focus on establishing one of the strongest portfolios of brands in key strategic U.S. markets. Backed by in-house expertise and cannabis domain knowledge, RIV Capital aims to grow its own brands and partner with established U.S. cannabis operators and brands to bring them to new markets and build market share. RIV Capital established the foundational building blocks of its active U.S. strategy with the previously announced acquisition (the “Etain Acquisition“) of Etain, LLC and Etain IP LLC (Through its strategic relationship with The Hawthorne Collective, Inc. (“The Hawthorne Collective“), a subsidiary of The ScottsMiracle-Gro Company (“ScottsMiracle-Gro“), RIV Capital is The Hawthorne Collective’s preferred vehicle for cannabis-related investments not under the purview of other ScottsMiracle-Gro subsidiaries.
(This information is primarily sourced from RIV Capital Inc. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).